Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cardiovascular risk factors in type 2 diabetes]

B Lesobre1

  • 1L'Institut Servier du Diabète, Neuilly/Seine.

Diabete & Metabolisme
|November 1, 1994
PubMed
Summary

Type 2 diabetes significantly increases coronary atherosclerosis risk, especially in females. While classic risk factors are more prevalent, specific diabetic complications and hyperglycemia appear to be key drivers of cardiovascular events.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of newly diagnosed non-insulin-dependent diabetes mellitus in the primary care setting: effects of 2 years of gliclazide treatment--the Diadem Study.

Metabolism: clinical and experimental·1998
Same author

[Non-insulin dependent diabetes. Role of gliclazide (diamicron)].

Journees annuelles de diabetologie de l'Hotel-Dieu·1995
Same author

[Glycogen synthetase and non-insulin-dependent diabetes: role of gliclazide].

Journees annuelles de diabetologie de l'Hotel-Dieu·1991
Same author

[Macroangiopathy and type 2 diabetes mellitus: significance of Diamicron].

Journees annuelles de diabetologie de l'Hotel-Dieu·1990
Same author

[Management and treatment of hyperosmolar coma].

Journees annuelles de diabetologie de l'Hotel-Dieu·1990
Same author

[Diamicron through the European Association for the Study of Diabetes and the International Diabetes Federation congresses in Sydney in 1988].

Journees annuelles de diabetologie de l'Hotel-Dieu·1989

Area of Science:

  • Cardiology
  • Endocrinology
  • Epidemiology

Context:

  • Type 2 diabetes patients face higher coronary atherosclerosis morbidity and mortality rates compared to non-diabetics.
  • Existing epidemiological data present methodological challenges in isolating specific risk factors.

Purpose:

  • To analyze the contribution of classic and specific risk factors to increased cardiovascular risk in Type 2 diabetes.
  • To investigate the roles of hyperglycemia and insulin levels in macrovascular complications.

Summary:

  • Diabetics exhibit higher rates of hypertension, dyslipidemia (low HDL, high triglycerides), and smoking.
  • Specific diabetic factors like microalbuminuria, retinopathy, elevated fibrinogen, PAI-1, Lp(a), and ACE gene polymorphism (DD allele) are implicated.
  • Hyperglycemia, not circulating insulin, is identified as the primary driver of macrovascular complications in established Type 2 diabetes.

Impact:

  • Highlights the multifactorial nature of cardiovascular risk in Type 2 diabetes.
  • Emphasizes hyperglycemia as a critical target for preventing macrovascular complications.
  • Informs clinical strategies for managing cardiovascular risk in diabetic populations.

Related Experiment Videos